• Lindian Resources secures heavy rare earths supply deal for SARECO facility

    A hand holding a lump of rare earths material against a blue sky.

    The Lindian Resources Ltd (ASX: LIN) share price is in focus today after the company announced it has secured an exclusive option to acquire 13,389 tonnes of heavy rare earths feedstock in Kazakhstan, with the potential to evaluate an additional 15,000 to 20,000 tonnes—all without upfront cash outlay.

    What did Lindian Resources report?

    • Exclusive option to acquire 13,389 tonnes of heavy rare earths (dysprosium, terbium, yttrium) from the Aktau Stockpile.
    • Over 7,500 tonnes prepared for transport, balance to be dried before shipping to the SARECO facility.
    • 12-month period of exclusive rights to evaluate an additional 15,000–20,000 tonnes of above-ground material.
    • No upfront cash payment for exclusivity or for the option to acquire.
    • Testing underway to assess composition; potential to broaden rare earth product suite.
    • Established rail logistics between Aktau and Stepnogorsk plant.

    What else do investors need to know?

    Lindian’s access to a large stockpile in Kazakhstan gives it an in-country feed source for its 100%-owned SARECO rare earth processing plant. This complements the company’s Kangankunde project in Malawi, which is focused on neodymium and praseodymium.

    There’s no resource or reserve yet defined for the Aktau Stockpile, and economic viability will depend on ongoing assay and testwork results. However, these tests could potentially confirm a new revenue stream from high-value heavy rare earths, helping Lindian diversify and strengthen its presence in the critical minerals market.

    The company currently enjoys a flexible arrangement and may, subject to permissions and successful testwork, move forward with both Aktau and Kangankunde as sources of supply for SARECO.

    What did Lindian Resources management say?

    Lindian Resources’ Executive Director Zac Komur, said:

    Aktau is strategically important because it was historically used as feedstock for SARECO, providing Lindian with the opportunity to re-establish an in-country rare earth feed source for the facility. Dy and Tb are among the most strategically important rare earths used in high-performance permanent magnets, while yttrium has important applications across aerospace, electronics and defence. Establishing meaningful exposure to these elements would materially broaden Lindian’s position across the rare earth value chain.

    What’s next for Lindian Resources?

    Lindian is undertaking sampling and metallurgical testwork at the Aktau site, with results expected in coming months. Subject to positive tests and regulatory approvals, the company could ramp up feed to its SARECO plant even before Kangankunde supply commences.

    In the medium term, Lindian’s strategy is to position SARECO as a flexible, multi-feed rare earths processing platform, serving end-markets with both light and heavy rare earth products. The company is also advancing Stage 1 development and feasibility work at Kangankunde, with first production targeted for late 2026.

    Lindian Resources share price snapshot

    Over the past 12 months, Lindian Resources shares have surged more than 200%, far outpacing the All Ordinaries Index (ASX: XAO).

    View Original Announcement

    The post Lindian Resources secures heavy rare earths supply deal for SARECO facility appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Lindian Resources right now?

    Before you buy Lindian Resources shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Lindian Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Here’s the dividend forecast out to 2029 for Wesfarmers shares

    Stacks of Australian dollar currency banknotes.

    Wesfarmers Ltd (ASX: WES) has been a compelling ASX dividend share for a number of years, and that could continue to be the case, based on projected payouts.

    Wesfarmers is the business behind a number of leading Australian retail names, including Bunnings, Kmart, Officeworks, Priceline, Target, and others.

    It also has a healthcare division and a chemicals, energy and fertiliser segment called WesCEF, which includes its lithium mining operations.

    The company has regularly produced impressive results for shareholders and FY26 was no different with solid underlying performance.

    In the 2026 financial year, Wesfarmers reported that underlying earnings per share (EPS) grew by 8.3% following 3.4% revenue growth. Bunnings Group saw earnings growth of 5.1% to $2.45 billion and Kmart Group saw earnings growth of 6% to $1.1 billion.

    FY27

    The company’s FY27 has started off solidly, with good sales growth for both Bunnings Group and Kmart Group. Those are the two core earnings drivers of the business, so it’s good to see the company has started FY26 in a good position.

    Wesfarmers said that in the first seven weeks of FY27, Bunnings’ sales growth was slightly stronger compared to the second half of FY26. Kmart Group sales growth was “in line” with the second half of FY26.

    Based on that trading update and commentary on the progress of the rest of the business (including the lithium segment), the projection on CommSec suggests Wesfarmers could grow EPS again in FY27 by around 10%.

    However, the current projection suggests the business could deliver an annual dividend per Wesfarmers share of $2.40. That translates into a potential grossed-up dividend yield of 4.3%, including franking credits.

    FY28

    The forecast suggests that Wesfarmers could increase its payout and earnings in the following financial year.

    According to the projection on CommSec, the company is projected to pay an annual dividend per Wesfarmers share of approximately $2.61 in FY28. This would translate into a possible grossed-up dividend yield of 4.7%, including franking credits.

    Depending on what happens with the lithium price, the Wesfarmers WesCEF division could play an important role in overall earnings generation.

    FY29

    For the final financial year of this series of projections, the annual payout could get even better.

    According to the projection on CommSec, the business could pay an annual dividend per Wesfarmers share of $2.71 in the 2029 financial year.

    If the business does deliver that level of passive income, it would translate into a grossed-up dividend yield of 4.9%, including franking credits.

    I think it’s one of the most impressive ASX blue-chip shares for dividends, though it’s certainly not cheap at this valuation.

    The post Here’s the dividend forecast out to 2029 for Wesfarmers shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Wesfarmers right now?

    Before you buy Wesfarmers shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Wesfarmers wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • GenusPlus gets green light for $750m TasNetworks build

    A team of people giving the thumbs up sign.

    The GenusPlus Group Ltd (ASX: GNP) share price is in focus today after the company announced it will begin construction on the first stage of the TasNetworks North West Transmission Developments project, with total works valued at around $750 million.

    What did GenusPlus report?

    • TasNetworks has issued a Notice to Proceed to GenusPlus for the Construction Phase of NWTD Stage 1
    • Construction work is set to commence immediately and is planned for completion in 2029
    • Total project value is approximately $750 million, including Early Works and Early Contractor Involvement phases ($122 million)
    • The project covers essential power infrastructure in Tasmania

    What else do investors need to know?

    The announcement follows several earlier updates from GenusPlus about its agreements with TasNetworks, most recently on 8 May 2026. The project is a major contract win for GenusPlus and represents a significant milestone in its growth, given the scale and long-term nature of the work.

    GenusPlus is set to play a central role in delivering critical infrastructure for Tasmania, aiming to create local employment and engage Tasmanian suppliers. This contract demonstrates the company’s ongoing strength in the utilities and infrastructure sector across Australia.

    What did GenusPlus management say?

    GenusPlus Managing Director, David Riches, said:

    Genus has worked closely with TasNetworks to reach this important milestone; and with the start of construction imminent we’re proud to move into the next phase of delivering this critical infrastructure for Tasmania and Australia. We’re committed to creating opportunities for Tasmanians throughout the project, from employing local people to engaging Tasmanian business and suppliers. By combining Genus’ capability and experience with local knowledge and expertise, we can deliver lasting value for the community.

    What’s next for GenusPlus?

    GenusPlus will now shift focus to delivering the construction phase of the TasNetworks NWTD project, with works scheduled until 2029. The company looks set to benefit from its expanded role as an essential service provider in the power and infrastructure sector.

    Investors can expect ongoing updates on project milestones and further information about GenusPlus’ strategy to collaborate with local businesses and deliver benefits to both Tasmania and broader Australia.

    GenusPlus share price snapshot

    Over the past 12 months, GenusPlus shares have risen 66%, outperforming the All Ordinaries Index (ASX: XAO).

    View Original Announcement

    The post GenusPlus gets green light for $750m TasNetworks build appeared first on The Motley Fool Australia.

    Should you invest $1,000 in GenusPlus Group right now?

    Before you buy GenusPlus Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and GenusPlus Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended GenusPlus Group. The Motley Fool Australia has recommended GenusPlus Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Financial statement inaccuracy

  • PFE | Pfizer and German partner BioNTech SE said Tuesday they’ve begun delivering doses of their coronavirus vaccine to US candidates with trials in Germany already underway.

  • PFE | Pfizer and German Parker BioNTech SE have begun delivering doses of their coronavirus vaccine for human testing US, trials in Germany already underway.

  • The performance outlook of tech companies.